BIO-key International (BKYI) to Post Earnings on Wednesday

BIO-key International (NASDAQ:BKYI) will likely be posting its Q2 2026 results before the market opens on Wednesday, August 12th. Analysts expect the company to announce earnings of ($0.82) per share and revenue of $1.80 million for the quarter. Investors can find conference call details on the company’s upcoming Q2 2026 earning summary page for the latest details on the call scheduled for Friday, August 14, 2026 at 10:00 AM ET.

BIO-key International Stock Performance

NASDAQ:BKYI opened at $4.03 on Monday. The company has a market capitalization of $4.39 million, a P/E ratio of -0.73 and a beta of 0.44. BIO-key International has a 12 month low of $3.10 and a 12 month high of $19.70. The firm has a fifty day simple moving average of $4.40 and a 200-day simple moving average of $5.31.

Wall Street Analyst Weigh In

A number of analysts have commented on the company. Weiss Ratings reaffirmed a “sell (e+)” rating on shares of BIO-key International in a research report on Friday, July 17th. Zacks Research raised BIO-key International to a “hold” rating in a report on Thursday. One equities research analyst has rated the stock with a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat.com, the company presently has an average rating of “Reduce”.

Hedge Funds Weigh In On BIO-key International

A hedge fund recently raised its position in BIO-key International stock. Geode Capital Management LLC lifted its stake in BIO-key International Inc. (NASDAQ:BKYI) by 49.9% during the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 48,892 shares of the technology company’s stock after buying an additional 16,271 shares during the quarter. Geode Capital Management LLC owned approximately 0.45% of BIO-key International worth $26,000 as of its most recent SEC filing. Institutional investors and hedge funds own 26.51% of the company’s stock.

BIO-key International Company Profile

BIO-key International, Inc is a developer and provider of fingerprint biometric identity and access management solutions, serving enterprise and government customers. The company’s core offerings include a range of fingerprint readers and authentication software designed to verify user identity across physical and digital environments. By leveraging proprietary template-on-card and template-on-device technologies, BIO-key seeks to enhance security and streamline user access without reliance on traditional passwords.

In addition to hardware sensors, BIO-key delivers software platforms that integrate with existing IT infrastructures such as Microsoft Active Directory and major workforce management systems.